| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |